Virtual Patent Marking

Second Heart Assist, Inc. develops products and technology for the treatment and prevention of heart disease such as heart failure (Cardio-Renal Syndrome (CRS) or Acute Decompensated Heart Failure (ADHF), which have uses in, for example, percutaneous coronary intervention (PCI), continuous off-loading of the heart for improved cardiac response, and angioplasty /kidney support for AKI, and Cardiogenic Shock (CS). This website page is provided to satisfy the virtual patent marking provisions of various jurisdictions, in particular it is intended to serve as Notice under 35 U.S.C. § 287(a). The products and technologies listed below may be distributed individually or as part of a combination product. Additional patent applications may also be pending in the United States and internationally.

Second Heart Assist Products and Technology
The following U.S. patents and applications apply to Second Heart Assist products and technology, including but not limited to the FreedomTM, WhisperTM, and RegeneratorTM circulatory assist pumps:

WhisperTM catheter-based circulatory assist pump:
US Patent Number 11,602,627.
Other patents pending.

FreedomTM wireless powered implant:
US Patent Number 11,602,627.

US Patent 8,764,621 for “Transcutaneous power transmission and communication for implanted heart assist and other devices”

US Patent 9,308,303 for “Transcutaneous power transmission and communication for implanted heart assist and other devices”

DE112012002922T5 for “Transcutaneous power transmission and communication for implanted heart assist and other devices”

Other patents pending.

RegeneratorTM circulatory assist pump:
US Patent Number 11,464,488.
US Patent Number 11,471,686.
US Patent Number 11,602,627.
Other patents pending.

See, also:
US Patent 7,163,385 for “Hydroimpedance pump”
US Patent 8,092,365 for “Resonant Multi-layered Impedance Pump”
US Patent 8,197,234 for “In-Line Actuator for Electromagnetic Operation”
US Patent 8,764,621 for “Transcutaneous power transmission and communication for implanted heart assist and other devices”
US Patent 9,308,303 for “Transcutaneous power transmission and communication for implanted heart assist and other devices”
US20190125932A1 (May 2, 2019) for “Preventing blood clot formation, calcification and/or plaque formation on blood contact surface(s)”
US20210077687A1 (March 18, 2021) for “Circulatory assist pump”
US20210236817A1 (August 5, 2021) for “Bioelectric stimulator”
US20210402184A1 (December 30, 2021) for “Klotho Modulation”
US20220331576A1 (October 20, 2022) for “Circulatory assist pump”
US20230075608A1 (March 9, 2023) for “Circulatory assist pumps, abdominal belts for charging circulatory assist pumps, deployment catheters, retrieval catheters, and related systems and methods”.
Other patents pending.

International Patents and Applications:
JP5147720B2 for “Resonant Multi-layered Impedance Pump”
CN1985089A for “In-Line Actuator for Electromagnetic Operation”
JP2008500494A for “In-Line Actuator for Electromagnetic Operation”
KR100811037B1 for “In-Line Actuator for Electromagnetic Operation”
DE112012002922T5 for “Transcutaneous power transmission and communication for implanted heart assist and other devices”
EP3768349A1 for “Circulatory assist pump.”